Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease—A Pediatric Perspective
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease—A Pediatric Perspective
Authors
Keywords
-
Journal
Frontiers in Pediatrics
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-08-04
DOI
10.3389/fped.2021.702719
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cardiovascular disease in children with chronic kidney disease
- (2021) Anne M. Kouri et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Fibroblast growth factor 23: are we ready to use it in clinical practice?
- (2020) Annet Bouma-de Krijger et al. JOURNAL OF NEPHROLOGY
- Heart Plasticity in Response to Pressure- and Volume-Overload: A Review of Findings in Compensated and Decompensated Phenotypes
- (2020) Fotios G. Pitoulis et al. Frontiers in Physiology
- Fibrosis growth factor 23 is a promoting factor for cardiac fibrosis in the presence of transforming growth factor-β1
- (2020) Kazuhiro Kuga et al. PLoS One
- Fibroblast growth factor 23: a biomarker of fibrosis and prognosis in heart failure with preserved ejection fraction
- (2020) Clotilde Roy et al. ESC Heart Failure
- Active vitamin D is cardioprotective in experimental uraemia but not in children with CKD Stages 3–5
- (2020) Anne Schön et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Management of Hypertension in Chronic Kidney Disease
- (2019) Dan Pugh et al. DRUGS
- Effects of Nicotinamide and Lanthanum Carbonate on Serum Phosphate and Fibroblast Growth Factor-23 in CKD: The COMBINE Trial
- (2019) Joachim H. Ix et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Arterial “inflammaging” drives vascular calcification in children on dialysis
- (2019) Pilar Sanchis et al. KIDNEY INTERNATIONAL
- Pre-analytical stability of FGF23 with the contemporary immunoassays
- (2019) Niek F. Dirks et al. CLINICA CHIMICA ACTA
- Impact of C-reactive protein on osteo-/chondrogenic transdifferentiation and calcification of vascular smooth muscle cells
- (2019) Laura A. Henze et al. Aging-US
- Single Measurements of Carboxy-Terminal Fibroblast Growth Factor 23 and Clinical Risk Prediction of Adverse Outcomes in CKD
- (2019) Daniel Edmonston et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- IL 6 but not TNF is linked to coronary artery calcification in patients with chronic kidney disease
- (2019) Joanna Kamińska et al. CYTOKINE
- FGF23-Mediated Activation of Local RAAS Promotes Cardiac Hypertrophy and Fibrosis
- (2019) Ineke Böckmann et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Indoxyl sulfate‐induced calcification of vascular smooth muscle cells via the PI3K/Akt/NF‐κB signaling pathway
- (2019) Xin He et al. MICROSCOPY RESEARCH AND TECHNIQUE
- Impaired Systolic and Diastolic Left Ventricular Function in Children with Chronic Kidney Disease - Results from the 4C Study
- (2019) Anke Doyon et al. Scientific Reports
- Highlight article: αKlotho attenuates cardiac hypertrophy and increases myocardial fibroblast growth factor 21 expression in uremic rats
- (2019) Paulo Giovani de Albuquerque Suassuna et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Risk factors for increased left ventricular hypertrophy in patients with chronic kidney disease: findings from the CKD-JAC study
- (2018) Kosaku Nitta et al. Clinical and Experimental Nephrology
- Markers of early progressive renal decline in type 2 diabetes suggest different implications for etiological studies and prognostic tests development
- (2018) Natalia Nowak et al. KIDNEY INTERNATIONAL
- Cardiac hypertrophy elevates serum levels of fibroblast growth factor 23
- (2018) Isao Matsui et al. KIDNEY INTERNATIONAL
- The elevation of circulating fibroblast growth factor 23 without kidney disease does not increase cardiovascular disease risk
- (2018) Eva-Maria Pastor-Arroyo et al. KIDNEY INTERNATIONAL
- OUP accepted manuscript
- (2018) NEPHROLOGY DIALYSIS TRANSPLANTATION
- Fibroblast growth factor 23 is induced by an activated renin–angiotensin–aldosterone system in cardiac myocytes and promotes the pro-fibrotic crosstalk between cardiac myocytes and fibroblasts
- (2018) Maren Leifheit-Nestler et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Paracrine Effects of FGF23 on the Heart
- (2018) Maren Leifheit-Nestler et al. Frontiers in Endocrinology
- Inflammation-Related Mechanisms in Chronic Kidney Disease Prediction, Progression, and Outcome
- (2018) Simona Mihai et al. Journal of Immunology Research
- Cardioprotective Effects of Paricalcitol Alone and in Combination With FGF23 Receptor Inhibition in Chronic Renal Failure: Experimental and Clinical Studies
- (2018) Brian Czaya et al. AMERICAN JOURNAL OF HYPERTENSION
- Data-driven discovery and validation of circulating blood-based biomarkers associated with prevalent atrial fibrillation
- (2018) Winnie Chua et al. EUROPEAN HEART JOURNAL
- Effect of lanthanum carbonate on coronary artery calcification and bone mineral density in maintenance hemodialysis patients with diabetes complicated with adynamic bone disease
- (2017) Chunhua Zhang et al. MEDICINE
- Vitamin D treatment attenuates cardiac FGF23/FGFR4 signaling and hypertrophy in uremic rats
- (2017) Maren Leifheit-Nestler et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Indoxyl Sulfate: A Novel Cardiovascular Risk Factor in Chronic Kidney Disease
- (2017) Szu‐Chun Hung et al. Journal of the American Heart Association
- FGF23/FGFR4-mediated left ventricular hypertrophy is reversible
- (2017) Alexander Grabner et al. Scientific Reports
- C-Reactive Protein and Risk of ESRD: Results From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)
- (2016) Finnian R. Mc Causland et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Effects of lanthanum carbonate and calcium carbonate on fibroblast growth factor 23 and hepcidin levels in chronic hemodialysis patients
- (2016) Yu-Ming Chang et al. Clinical and Experimental Nephrology
- Fibroblast Growth Factor 23 and Risk of CKD Progression in Children
- (2016) A. A. Portale et al. Clinical Journal of the American Society of Nephrology
- Patients with FGF23-related hypophosphatemic rickets/osteomalacia do not present with left ventricular hypertrophy
- (2016) Yuichi Takashi et al. ENDOCRINE RESEARCH
- Cardiorenal syndrome type 4: From chronic kidney disease to cardiovascular impairment
- (2016) Antonio Granata et al. European Journal of Internal Medicine
- Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease
- (2016) Saurav Singh et al. KIDNEY INTERNATIONAL
- FGF-23 and Osteoprotegerin but not Fetuin-A are associated with death and enhance risk prediction in non-dialysis chronic kidney disease stages 3-5.
- (2016) Helen V Alderson et al. NEPHROLOGY
- Fibroblast growth factor 23 modifies the pharmacological effects of angiotensin receptor blockade in experimental renal fibrosis
- (2016) Maarten A. de Jong et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Oxidative Stress Biomarkers and Left Ventricular Hypertrophy in Children with Chronic Kidney Disease
- (2016) Dorota Drożdż et al. Oxidative Medicine and Cellular Longevity
- Dyslipidemia, carotid intima-media thickness and endothelial dysfunction in children with chronic kidney disease
- (2016) Priyanka Khandelwal et al. PEDIATRIC NEPHROLOGY
- Association of Fibroblast Growth Factor 23 With Atrial Fibrillation in Chronic Kidney Disease, From the Chronic Renal Insufficiency Cohort Study
- (2016) Rupal Mehta et al. JAMA Cardiology
- Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy
- (2015) Alexander Grabner et al. Cell Metabolism
- Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in HemodialysisCLINICAL PERSPECTIVE
- (2015) Sharon M. Moe et al. CIRCULATION
- Fibroblast Growth Factor 23 Is an Independent and Specific Predictor of Mortality in Patients With Heart Failure and Reduced Ejection Fraction
- (2015) Lorenz Koller et al. Circulation-Heart Failure
- Elevated Ejection-Phase Myocardial Wall Stress in Children With Chronic Kidney DiseaseNovelty and Significance
- (2015) Haotian Gu et al. HYPERTENSION
- Experimental Myocardial Infarction Upregulates Circulating Fibroblast Growth Factor-23
- (2015) Olena Andrukhova et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The failing heart is a major source of circulating FGF23 via oncostatin M receptor activation
- (2015) Manfred Richter et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Fracture Burden and Risk Factors in Childhood CKD: Results from the CKiD Cohort Study
- (2015) M. R. Denburg et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Cause of Death in Patients with Reduced Kidney Function
- (2015) S. Thompson et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Induction of cardiac FGF23/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease
- (2015) Maren Leifheit-Nestler et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Relationship of FGF23 to indexed left ventricular mass in children with non-dialysis stages of chronic kidney disease
- (2015) Manish D. Sinha et al. PEDIATRIC NEPHROLOGY
- Vascular calcification: Mechanisms of vascular smooth muscle cell calcification
- (2015) Jane A. Leopold TRENDS IN CARDIOVASCULAR MEDICINE
- Association between Inflammation and Cardiac Geometry in Chronic Kidney Disease: Findings from the CRIC Study
- (2015) Jayanta Gupta et al. PLoS One
- Inflammation and Atherosclerosis
- (2014) Joshua Hartman et al. Cardiology in Review
- Dietary phosphorus restriction by a standard low-protein diet decreased serum fibroblast growth factor 23 levels in patients with early and advanced stage chronic kidney disease
- (2014) Shunsuke Goto et al. Clinical and Experimental Nephrology
- FGF23 regulates renal sodium handling and blood pressure
- (2014) Olena Andrukhova et al. EMBO Molecular Medicine
- Fibroblast Growth Factor-23, Cardiovascular Prognosis, and Benefit of Angiotensin-Converting Enzyme Inhibition in Stable Ischemic Heart Disease
- (2014) Jacob A. Udell et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Mortality Prediction Using Modern Peptide Biomarkers in Hemodialysis Patients - A Comparative Analysis
- (2014) Ferruh Artunc et al. KIDNEY & BLOOD PRESSURE RESEARCH
- Treatment of established left ventricular hypertrophy with fibroblast growth factor receptor blockade in an animal model of CKD
- (2014) G. S. Di Marco et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Fibroblast Growth Factor‐23 and Incident Coronary Heart Disease, Heart Failure, and Cardiovascular Mortality: The Atherosclerosis Risk In Communities Study
- (2014) Pamela L. Lutsey et al. Journal of the American Heart Association
- Paricalcitol Downregulates Myocardial Renin-Angiotensin and Fibroblast Growth Factor Expression and Attenuates Cardiac Hypertrophy in Uremic Rats
- (2013) M. Freundlich et al. AMERICAN JOURNAL OF HYPERTENSION
- Method-specific differences in plasma fibroblast growth factor 23 measurement using four commercial ELISAs
- (2013) Edward R. Smith et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Disordered FGF23 and Mineral Metabolism in Children with CKD
- (2013) A. A. Portale et al. Clinical Journal of the American Society of Nephrology
- Effects of Dietary Phosphate Restriction and Phosphate Binders on FGF23 Levels in CKD
- (2013) T. Isakova et al. Clinical Journal of the American Society of Nephrology
- FGF23 concentrations measured using “intact” assays similar but not interchangeable
- (2013) Manish D. Sinha et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Cardiorenal Syndrome Type 4: A Review
- (2013) Anna Clementi et al. CardioRenal Medicine
- FGF23 adds value to risk prediction in patients with chronic kidney disease
- (2012) Edward R. Smith et al. BONE
- Effects of Sevelamer on HbA1c, Inflammation, and Advanced Glycation End Products in Diabetic Kidney Disease
- (2012) H. Vlassara et al. Clinical Journal of the American Society of Nephrology
- Biological Variability of Plasma Intact and C-Terminal FGF23 Measurements
- (2012) Edward R. Smith et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- FGF23 neutralization improves chronic kidney disease–associated hyperparathyroidism yet increases mortality
- (2012) Victoria Shalhoub et al. JOURNAL OF CLINICAL INVESTIGATION
- Fibroblast Growth Factor-23 and Death, Heart Failure, and Cardiovascular Events in Community-Living Individuals
- (2012) Joachim H. Ix et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Fibroblast growth factor 23 and left ventricular hypertrophy in children on dialysis
- (2012) Wacharee Seeherunvong et al. PEDIATRIC NEPHROLOGY
- A Comparative Transcriptome Analysis Identifying FGF23 Regulated Genes in the Kidney of a Mouse CKD Model
- (2012) Bing Dai et al. PLoS One
- Cellular Senescence, Vascular Disease, and Aging
- (2011) Jason C. Kovacic et al. CIRCULATION
- Cellular Senescence, Vascular Disease, and Aging
- (2011) Jason C. Kovacic et al. CIRCULATION
- Arterial Calcification in Chronic Kidney Disease: Key Roles for Calcium and Phosphate
- (2011) Catherine M. Shanahan et al. CIRCULATION RESEARCH
- Instability of fibroblast growth factor-23 (FGF-23): Implications for clinical studies
- (2011) Edward R. Smith et al. CLINICA CHIMICA ACTA
- Cardiac Geometry in Children Receiving Chronic Peritoneal Dialysis: Findings from the International Pediatric Peritoneal Dialysis Network (IPPN) Registry
- (2011) S. A. Bakkaloglu et al. Clinical Journal of the American Society of Nephrology
- The phosphatonin fibroblast growth factor 23 links calcium–phosphate metabolism with left-ventricular dysfunction and atrial fibrillation
- (2011) Sarah Seiler et al. EUROPEAN HEART JOURNAL
- Inorganic phosphate and FGF-23 predict outcome in stable systolic heart failure
- (2011) Max Plischke et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- FGF23 induces left ventricular hypertrophy
- (2011) Christian Faul et al. JOURNAL OF CLINICAL INVESTIGATION
- Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease
- (2011) Tamara Isakova et al. KIDNEY INTERNATIONAL
- Effects of Dietary Phosphate and Calcium Intake on Fibroblast Growth Factor-23
- (2010) M. G. Vervloet et al. Clinical Journal of the American Society of Nephrology
- Blood Pressure Control and Left Ventricular Mass in Children with Chronic Kidney Disease
- (2010) M. D. Sinha et al. Clinical Journal of the American Society of Nephrology
- Does indoxyl sulfate, a uraemic toxin, have direct effects on cardiac fibroblasts and myocytes?
- (2010) S. Lekawanvijit et al. EUROPEAN HEART JOURNAL
- Hemodialysis
- (2010) Jonathan Himmelfarb et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular Disease in CKD in Children: Update on Risk Factors, Risk Assessment, and Management
- (2009) Amy C. Wilson et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Masked Hypertension Associates with Left Ventricular Hypertrophy in Children with CKD
- (2009) M. Mitsnefes et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Indoxyl sulphate induces oxidative stress and the expression of osteoblast-specific proteins in vascular smooth muscle cells
- (2009) G. Muteliefu et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Overview of the FGF23-Klotho axis
- (2009) Makoto Kuro-o PEDIATRIC NEPHROLOGY
- Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation
- (2009) R. Goetz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Indoxyl sulphate promotes aortic calcification with expression of osteoblast-specific proteins in hypertensive rats
- (2008) A. Adijiang et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started